#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5136647	T	Cytotoxicity against human Calu-3 cells assessed as reduction in cell virion production at 10 uM incubated for 24 hrs by cell titer glo luminescent assay	Homo sapiens	19		cell-based format	Scientific Literature
2.	ALA5136648	B	Inhibition of recombinant his tagged SARS CoV-2 main protease expressed in Escherichia coli BL21 using Boc-Abu-Tle-Leu-Gln-AMC37 as fluorogenic substrate pre-incubated for 5 mins followed by substrate addition measured after 60 mins by FRET based assay	Severe acute respiratory syndrome coronavirus 2	33		assay format	Scientific Literature
3.	ALA5136650	B	Inhibition of recombinant his tagged SARS CoV-2 main protease expressed in Escherichia coli BL21 assessed as inhibition constant using Boc-Abu-Tle-Leu-Gln-AMC37 as fluorogenic substrate pre-incubated for 5 mins followed by substrate addition measured after 60 mins by FRET based assay	Severe acute respiratory syndrome coronavirus 2	29		assay format	Scientific Literature
4.	ALA5136651	B	Time dependent inhibition of recombinant his tagged SARS CoV-2 main protease expressed in Escherichia coli BL21 assessed as ratio of Kinact/Ki using MCA-AVLQSGFR-K(DNP)-K-NH2 as substrate pre-incubated for 5 mins followed by substrate addition measured after 60 mins by FRET based assay	Severe acute respiratory syndrome coronavirus 2	33		assay format	Scientific Literature
5.	ALA5136652	T	Cytotoxicity against African green monkey Vero 76 cells assessed as reduction in cell virion production at 10 uM incubated for 24 hrs by cell titer glo luminescent assay	Chlorocebus sabaeus	19		cell-based format	Scientific Literature
6.	ALA5136653	F	Antiviral activity against SARS-COV 2 infected in human Calu-3 cells assessed as inhibition of viral replication preincubated for 1 hr followed by viral infection and further incubated with compound for 24 hrs	Severe acute respiratory syndrome coronavirus 2	12		organism-based format	Scientific Literature
7.	ALA5136654	F	Antiviral activity against SARS-COV 2 infected in Vero 76 cells assessed as inhibition of viral replication preincubated for 1 hr followed by viral infection and further incubated with compound for 24 hrs	Severe acute respiratory syndrome coronavirus 2	5		organism-based format	Scientific Literature
8.	ALA5136655	B	Inhibition of recombinant SARS CoV-1 main protease expressed using MCA-AVLQSGFR-K(DNP)-K-NH2 as substrate incubated for 2 hrs by FRET based assay	Severe acute respiratory syndrome-related coronavirus	17		assay format	Scientific Literature
9.	ALA5136656	B	Inhibition of MERS-CoV -Mpro using Ac-Abu-Tle-Leu-Gln-ACC as substrate incubated for 2 hrs by FRET based assay	Middle East respiratory syndrome-related coronavirus	17		assay format	Scientific Literature